Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|5|2039-2046

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.5, 2015-01, pp. : 2039-2046

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genome-wide transcriptome analysis reveals inactivation of Wnt/β-catenin by 3,3'-diindolylmethane inhibiting proliferation of colon cancer cells

By          

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 918-926

Spandidos Publications

Access to resources Recommend Favorite

Müllerian Inhibiting Substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers

By MacLaughlin David T   Donahoe Patricia K  

Future Oncology, Vol. 6, Iss. 3, 2010-03 ,pp. : 391-405

Future Medicine

Access to resources Recommend Favorite

The EMT signaling pathways in endometrial carcinoma

By Colas Eva  

Clinical and Translational Oncology, Vol. 14, Iss. 10, 2012-10 ,pp. : 715-720

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 2013-2021

Spandidos Publications

Access to resources Recommend Favorite

Transcriptome analysis reveals the effect of oral contraceptive use on cervical cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1703-1708

Spandidos Publications

Access to resources Recommend Favorite